Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients:
- People who have been diagnosed with a specific type of frontotemporal dementia (bvFTD) or Alzheimer's disease (AD), confirmed using recognised international diagnostic guidelines
- People who have no signs of any other brain conditions
- People who score 10 or above on a standard memory and thinking test called the MMSE, which helps ensure results are not affected by very severe cognitive difficulties
- People aged between 40 and 85
- People who have no psychiatric conditions and score below 20 on a standardised depression rating scale, to make sure depression is not confused with apathy
- People who do not take large amounts of calming or sedating medications, such as sleeping pills or benzodiazepines
- People who do not have a major physical disability that affects their ability to move around
- People who do not have a heart pacemaker, as this would interfere with heart rate measurements
For caregivers and healthy control partners:
- People aged between 40 and 85
- People who have no psychiatric conditions and score below 20 on the standardised depression rating scale
- People who do not take large amounts of calming or sedating medications
- People who do not have a major physical disability that affects their ability to move around
- People who do not have a heart pacemaker
Who may not be able to join:
- People who are currently detained by a court or government authority
- People who are under a legal protection order (confirm with trial site)
- People who are currently in an exclusion period because of participation in another research study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Richard Levy, MD, PhD, Institut National de la Santé Et de la Recherche Médicale, France
Phone: 01 49 28 24 32
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acceleration (in g); Electrodermal activity (in microsiemens); Blood volume pulse (or relative blood flow); Bedtime and getting up time (Week 1); Bedtime and getting up time (Week 2); Bedtime and getting up time (Week 3); Bedtime and getting up time (Week 4); Meal times (Week 1); Meal times (Week 2); Meal times (Week 3); Meal times (Week 4); Autonomy for going to bed and getting up (Week 1); Autonomy for going to bed and getting up (Week 2); Autonomy for going to bed and getting up (Week 3); Autonomy for going to bed and getting up (Week 4); Signs of tiredness (Week 1); Signs of tiredness (Wee...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.